| D008297 |
Male |
|
Males |
|
| D009761 |
Nystatin |
Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. |
Fungicidin,Mycostatin,Nilstat,Nystatin A1,Nystatin A2,Nystatin A3,Nystatin G,Stamicin,Stamycin |
|
| D002177 |
Candidiasis |
Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) |
Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases |
|
| D003881 |
Dermatomycoses |
Superficial infections of the skin or its appendages by any of various fungi. |
Skin Diseases, Fungal,Dermatomycosis,Dermatophyte Infection,Fungal Skin Diseases |
|
| D003883 |
Arthrodermataceae |
A family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. Genera in the family include Arthroderma, Keratinomyces, and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin. |
Arthroderma,Ctenomyces,Dermatophytes,Keratinomyces,Cutaneous Fungi,Cutaneous Fungus,Dermatomyces,Nannizzia,Arthrodermas,Ctenomyce,Dermatomyce,Dermatophyte,Fungi, Cutaneous,Fungus, Cutaneous,Keratinomyce,Nannizzias |
|
| D005260 |
Female |
|
Females |
|
| D006118 |
Griseofulvin |
An antifungal agent used in the treatment of TINEA infections. |
Fulvicin-U-F,Grifulvin V,Gris-PEG,Grisactin,Grisefuline,Fulvicin U F,FulvicinUF,Gris PEG,GrisPEG |
|
| D006204 |
Hair Removal |
Methods used to remove unwanted facial and body hair. |
Depilation,Electrolytic Depilation,Epilation,Depilation, Electrolytic,Depilations,Depilations, Electrolytic,Electrolytic Depilations,Epilations,Hair Removals,Removal, Hair,Removals, Hair |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000287 |
Administration, Topical |
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. |
Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations |
|